| Literature DB >> 32270956 |
Aleksandr Zotov1, Sergei Vachev1, Daniil Borisov1, Aleksandr Troitskiy1, Robert Khabazov1.
Abstract
OBJECTIVE: To evaluate the efficacy and safety of a modified technique for totally thoracoscopic left atrial posterior wall and pulmonary vein isolation in patients with long-standing persistent atrial fibrillation.Entities:
Keywords: Atrial Fibrillation; Ischemic Attack, Transient; Myocardial Infarction; Postoperative Complications; Pulmonary Veins; Sternotomy; Thoracotomy
Mesh:
Year: 2020 PMID: 32270956 PMCID: PMC7089748 DOI: 10.21470/1678-9741-2019-0132
Source DB: PubMed Journal: Braz J Cardiovasc Surg ISSN: 0102-7638
Clinical and demographic characteristics of the patients (n=28).
| Male, number of pts (N [%]) | 21 [75%] |
| Age, years (median [min-max]) | 60 [42-73] |
| Body mass index (median [min-max]) | 29 [23-40] |
| Duration of atrial fibrillation, months (median [min-max]) | 113 [12-485] |
| History of thromboembolic complications, number of pts (N [%]) | 3 [10.7%] |
| Stroke | 2 |
| Pulmonary embolism | 1 |
| Indexed left atrium volume, ml/m2 (median [min-max]) | 42 [28-57] |
| Left ventricular ejection fraction, Simpson, % (median [min-max]) | 55 [38-66] |
| Pulmonary artery pressure, mmHg (median [min-max]) | 32 [26-49] |
| Hypertension, number of pts (N [%]) | 25 [89.3%] |
| Drug-refractory tachycardia (> 90/min), number of pts (N [%]) | 11 [39.3%] |
| Endocardial RFA of pulmonary veins in the past, number of pts (N [%]) | 3 [10.7%] |
| Endocardial RFA of cava-tricuspid isthmus in the past, number of pts (N [%]) | 2 [7.1%] |
pts=patients; RFA=radiofrequency ablation
Fig. 1Scheme of the left atrial ablation lines.
Fig. 2Left atrial posterior wall ablation.
Postoperative results (n=28).
| Surgery time, minutes (median [min-max]) | 137 [118-193] |
| Ablation time, minutes (median [min-max]) | 29 [23-42] |
| Intubation time, hours (median [min-max]) | 8 [3-36] |
| Time with chest tubes, hours (median [min-max]) | 28 [16-74] |
| Intensive care unit stay, days (median [min-max]) | 1 [0.6-8] |
| Hospital stay, days (median [min-max]) | 5 [3-13] |
| Postoperative complications | |
| Need for blood product transfusion, number of pts (N [%]) | 0 |
| Incidence of pneumonia, number of pts (N [%]) | 0 |
| Need for reintubation, number of pts (N [%]) | 0 |
| Unilateral phrenic nerve palsy, number of pts (N [%]) | 2 [7.1%] |
| Transient bilateral phrenic nerve palsy with prolonged non-invasive ventilation, number of pts (N [%]) | 1 [3.6%] |
pts=patients
| Abbreviations, acronyms & symbols | |
|---|---|
| AF | = Atrial fibrillation |
| CM III | = Cox-Maze III |
| LA | = Left atrium |
| pts | = Patients |
| PV | = Pulmonary veins |
| RFA | = Radiofrequency ablation |
| Author's roles & responsibilities | |
|---|---|
| AZ | Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; drafting the work or revising it critically for important intellectual content; agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved; final approval of the version to be published |
| SV | Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; drafting the work or revising it critically for important intellectual content; agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved; final approval of the version to be published |
| DB | Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; drafting the work or revising it critically for important intellectual content; agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved; final approval of the version to be published |
| AT | Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; drafting the work or revising it critically for important intellectual content; agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved; final approval of the version to be published |
| RK | Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; drafting the work or revising it critically for important intellectual content; agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved; final approval of the version to be published |